Skip to main content
. 2016 Jun 28;353:i3323. doi: 10.1136/bmj.i3323

Table 2.

Characteristics of new devices granted Conformité Européenne (CE) marking between 2005 and 2010

Novel medical devices (n=309) No (%)
Therapeutic area:
 Cardiovascular 245 (79)
 Neurologic 28 (9)
 Orthopedic 36 (12)
CE marking year:
 2005 29 (9)
 2006 37 (12)
 2007 36 (12)
 2008 57 (18)
 2009 79 (26)
 2010 71 (23)
Firm type:
 Small (<$1bn) 134 (44)
 Large (≥$1bn) 174 (56)
Food and Drug Administration approval:
 Yes 206 (67)
 No 103 (33)
Major innovation:
 Yes 75 (24)
 No 234 (76)